Thus, on the basis of the above, it is plausible that simultaneously targeting all members of the CoREST complex—especially through degradation to abrogate scaffolding properties—could more profoundly disrupt the oncogenic programs governed by GFI1 and other pathogenic factors in leukemia. This evidence concerns the gene GFI1 and leukemia.